Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enliven Therapeutics (ELVN) Change in Account Payables (2019 - 2026)

Enliven Therapeutics has reported Change in Account Payables over the past 8 years, most recently at -$519000.0 for Q1 2026.

  • Quarterly results put Change in Account Payables at -$519000.0 for Q1 2026, down 335.91% from a year ago — trailing twelve months through Mar 2026 was $78000.0 (up 106.93% YoY), and the annual figure for FY2025 was $817000.0, up 0.86%.
  • Change in Account Payables reached -$519000.0 in Q1 2026 per ELVN's latest filing, down from $828000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $2.2 million in Q1 2024 and bottomed at -$1.6 million in Q2 2024.
  • Median Change in Account Payables over the past 5 years was $18000.0 (2022), compared with a mean of -$43000.0.
  • The largest annual shift saw Change in Account Payables skyrocketed 1005.33% in 2022 before it plummeted 5438.89% in 2023.
  • Over 5 years, Change in Account Payables stood at $18000.0 in 2022, then tumbled by 5438.89% to -$961000.0 in 2023, then skyrocketed by 133.61% to $323000.0 in 2024, then skyrocketed by 156.35% to $828000.0 in 2025, then tumbled by 162.68% to -$519000.0 in 2026.
  • Business Quant data shows Change in Account Payables for ELVN at -$519000.0 in Q1 2026, $828000.0 in Q4 2025, and -$1.0 million in Q3 2025.